Jinghua Pharmaceutical announced that the company plans to add the traditional Chinese medicine type Ji Desheng Snake Pill to add treatment for shingles. The company recently received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration. The relevant clinical trial application was approved on October 8, 2026, and subsequent phase II and III clinical trials will be carried out as required.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.